OPTISCAN IMAGING LIMITED (OIL)

Latest AI Signal: BUY
Status: EXPIRED
Days Old: 57

Confidence: 45%

Date: 25-03-2026

Price: $0.100

Last Price: $0.107

Post-Signal Peak Price: $0.120

Latest  OPTISCAN IMAGING LIMITED(OIL)   News

18 Jul 2025, 01:05 PM

ASX Penny Stocks To Consider In July 2025

The Australian sharemarket is experiencing a bullish trend, with the ASX 200 futures rising and the local bourse reaching new all-time highs, driven by U.S. market momentum and economic indicators suggesting potential rate cuts. In this context, identifying good stocks involves looking for those wit

BUY Confidence Low

AI Confidence - 45 % model confidence

Business Overview

Optiscan Imaging Limited develops and commercializes advanced optical imaging technologies primarily for medical applications, including cancer diagnostics and surgical guidance. The company holds a niche position in the medical imaging market with proprietary confocal microscopy technology, targeting high-growth sectors such as oncology and neurosurgery.

Financial Analysis

Cash Flow	Weak
Debt	Low
Profitability	Weak
Revenue Trend	Unknown

Technical Analysis

Trend	Bullish
Momentum	Moderate
RSI Signal	Neutral
Support Level	$ 0.090
Resistance Level	$ 0.120

Valuation

Valuation - Undervalued

The stock trades at a low price with limited market capitalization, suggesting undervaluation relative to its technology potential and upcoming catalysts.

Catalysts

• Potential regulatory approvals or clinical trial results validating technology efficacy.

• Strategic partnerships or licensing deals expanding market reach.

• Increased adoption of optical imaging in surgical oncology driving revenue growth.

Recommendation

Action - Buy

Timeframe - Medium Term

Optiscan presents a compelling risk-reward profile given its innovative imaging technology and niche market position. While financial metrics remain weak, upcoming catalysts and technical signals support a medium-term buy recommendation.